Skip to Content
Shadow

Press Releases

Press Releases

Date Title and Summary Additional Formats
Toggle Summary Agile Therapeutics to Present at the Cantor Fitzgerald's 2nd Annual Healthcare Conference
Presentation Scheduled on Wednesday, July 13th, 2016 at 1:00 PM ET ...
Toggle Summary Agile Therapeutics Announces Issuance of Patent for Progestin Patch Designs
Intellectual Property Portfolio Broadened for Its Proprietary Transdermal Delivery System...
Toggle Summary Agile Therapeutics to Present at the William Blair & Company's 36th Annual Growth Stock Conference
Presentation Scheduled on Tuesday, June 14th, 2016 at 2:50 PM Central Time...
Toggle Summary Agile Therapeutics to Present at the Jefferies 2016 Healthcare Conference
Presentation Scheduled on Friday, June 10th, 2016 at 10:30 AM Eastern Time...
Toggle Summary Agile Therapeutics Reports First Quarter 2016 Financial Results
Cash Expected to Fund Operations through the End of 2017 Clinical Trial Expected to Complete in Fourth Quarter 2016 and Resubmission Planned for First Half 2017 PRINCETON, N.J., May 09, 2016 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women's health specialty pharmaceutical...
Toggle Summary Agile Therapeutics to Present at Women's Health 2016: The 24th Annual Congress
PRINCETON, N.J. , April 15, 2016 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX) a women's health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products announced today that Dr....
Toggle Summary Agile Therapeutics to Present at the 15th Annual Needham Healthcare Conference
Presentation Scheduled on Wednesday, April 13, 2016 at 4:20 PM Eastern Time...
Toggle Summary Agile Therapeutics Reports Fourth Quarter and Full Year 2015 Financial Results
Cash Expected to Fund Operations Through the End of 2017...
Toggle Summary Agile Therapeutics to Present at the 28th Annual ROTH Conference
Presentation Scheduled on Monday, March 14, 2016 at 7:30 AM Pacific Time...
Toggle Summary Agile Therapeutics Appoints Ajit S. Shetty, Ph.D., to Its Board of Directors
Andrew Schiff, M.D. to Step Down From the Board...
Shadow